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LETTER TO THE EDITOR
months) were compared with 19 untreated patients.The urinary excretion of IgG
There was no difference in remission or progression rate
between treated and untreated patients when IgG andand 1-microglobulin predicts 1m excretion was less than the cutoff; a significant differ-
ence for progression to CRF between treated and un-renal outcome and identifies treated was observed when1m excretion was greater than
the cutoff (17% versus 100%; P  0.0076). An Editorialpatients deserving treatment comment of Wasserstein [3] stressed that whereas meta-
analyses of hundred of patients [4, 5] have failed to showin membranous nephropathy a benefit of immunosuppressive treatment on progres-
sion, our study has hinted at such a benefit in a mere 38
patients stratified for risk. We suggest that the measure-To the Editor: In the January 2002 issue of Kidney
ment of urinary excretion of these two proteins maybeInternational Cattran [1] briefly reviewed the controversy
a valuable marker of risk, able to predict the renal out-about the treatment of membranous nephropathy (MN).
come, and identify the patients who should be treatedIts variable course underlines the importance of finding
with immunosuppressive therapy soon after diagnosis.an accurate predictor of renal outcome useful to identify
the patients who should be treated soon after diagnosis. Claudio Bazzi and Giuseppe D’Amico
We recently published a study [2] of 78 patients with Milan, Italy
MN. The urinary excretion of IgG and 1-microglobulin Correspondence to Claudio Bazzi, M.D., Division of Nephrology
(1m) was measured in second-morning urine samples and Dialysis, San Carlo Borromeo Hospital, Via Pio II, n. 3, 20153,
Milan, Italy.and expressed in milligrams per gram of urinary creati-
E-mail:giuseppe.damico@oscb.sined.netnine (mg/g UCr). The excretion of IgG and 1m was sig-
nificantly associated with the extent of tubulointerstitial
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